Gerson Lehrman Group - Intelligently Connecting Institutions and Expertise.

Study Group: Juvederm Users: Cosmetic Dermatologists (US)

Council Members in this Study Group: 134

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Contact Gerson Lehrman Group to survey or consult with members of this Study Group

Leading institutions connect with members of this Study Group through GLG

Leading Experts in this Study Group

Sunil Dhawan, MD, Clinical Assistant Professor of Dermatology, STANFORD UNIVERSITYSunil Dhawan, MD

Clinical Assistant Professor of Dermatology
STANFORD UNIVERSITY
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Sunil Dhawan, MD, is a Clinical Assistant Professor of Dermatology at Stanford University. He has expertise in clinical dermatology including acne, rosacea, psoriasis, eczema, skin cancer, actinic keratosis, lasers and cosmetic dermatology, and managed care. Dr. Dhawan also runs the clinical trialdivision...

Brian Lester, MD

Dermatologist
Brian W Lester, MD
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Brian Lester, MD, is a Dermatologist in private practice in Massachusetts. His interests include clinical dermatology, cosmetic dermatology, dermatopathology, and dermatologic pharmaceuticals. He has experience with clinical trials involving a variety of agents used in psoriasis (e.g. retinoids and...

Sanjay Rao, MD, Medical Director, Lakeside Eye ClinicSanjay Rao, MD

Medical Director
Lakeside Eye Clinic
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Sanjay Rao, MD, is the Medical Director and Director of Cornea and Refractive Surgery at the Lakeside Eye Clinic in Chicago. He was previously the Director of Cornea and Refractive Surgery at the University of Chicago. He has clinical expertise in diseases of the cornea and is a high volume cataract,...

David Portman, MD, Director, COLUMBUS CENTER FOR WOMENS HEALTH RESEARCHDavid Portman, MD

Director
COLUMBUS CENTER FOR WOMENS HEALTH RESEARCH
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

David Portman, MD, is Director and Principal Investigator of the Columbus Center for Women's Health Research. Dr. Portman is also a Clincial Investigator at The Ohio State University. He has conducted over 100 clinical studies in areas of contraception, osteoporosis, menopause, and sexual dysfunction...

Michele Pauporte, MD, Dermatologist, JUVA SKIN LASER CENTER INCMichele Pauporte, MD

Dermatologist
JUVA SKIN LASER CENTER INC
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Michele Pauporte, MD, is a dermatologist at Juva Skin and Laser Center, in New York City. Dr. Pauporte's areas of expertise include cosmetic procedures and the treatment of skin cancers, including Mohs micrographic surgery and reconstructive surgery. She is also extremely experienced in the use oflasers,...

Adam Schaffner, Assistant Professor of Clinical Plastic Surgery, Georgetown University Medical Center - CCAdam Schaffner

Assistant Professor of Clinical Plastic Surgery
Georgetown University Medical Center - CC
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Adam D. Schaffner, MD, FACS, is an Assistant Professor of Clinical Plastic and Reconstructive Surgery, Georgetown University Medical Center. He has previously served as a Clinical Assistant Professor of Otorhinolaryngology at Weill Cornell Medical College in New York City. He is board certified inotolaryngology...

Gregory Buford, MD, Plastic Surgeon and Medical Director , BEAUTY by BUFORDGregory Buford, MD

Plastic Surgeon and Medical Director
BEAUTY by BUFORD
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Gregory Buford, MD, is a board-certified Plastic Surgeon and Medical Director at Beauty By Buford in Colorado, since January 2008. Dr. Buford has residencies in both General Surgery and Plastic Surgery at the Cleveland Clinic Foundation, in addition to a Cosmetic Surgery Fellowship at Plastic Surgery...

Michael Bain, MD

Plastic and Reconstructive Physician
Michael A Bain, MD
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Michael Bain, MD, MS, is a Plastic and Reconstructive Physician in private practice based in Southern California. He has experience in all areas of plastic and reconstructive surgery including bariatric, breast, cosmetic, and reconstructive surgery. Dr. Bain’s interests are in the ever changing nature...

View all Leading Experts in this Study Group

GLG NewsSM Analyses by this Study Group's Leading Experts (?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.

Presta Trial shows good results for Enbrel

October 14, 2009

Sunil Dhawan, MD, Clinical Assistant Professor of Dermatology, STANFORD UNIVERSITY

New data from PRESTA trial demonstrate the benefit of Enbrel in patients with psoriasis & psoriatic arthritis | www.pharmabiz.com

This trial showed predicatably good results for Enbrel in patients with psoriasis and psoriatic arthritis. This included improvement in signs and symptoms and quality of life. This will increase sales of Enbrel in the short term. However the two newer agents, Humira and Stelara have better efficacy,...

NO BRAINER: Genentech Prefers to Promote Lucentis over Avastin for Wet ARMD

October 7, 2009

Genentech revisits plan for Avastin | www.sfgate.com

It does not require a lot of ophthalmic and business savy to understand why a company rather promote a drug that costs more than 20 times more to treat the same medical condition.

Peplin could be beneficial.

July 26, 2009

Peplin Initiates its Final Phase 3 Clinical Trial for PEP005 Gel in AK | www.pipelinereview.com

New product that only requires 2 application days over an area.  May be useful.  Typical source for a product like this, coming from a plant extract.  Considering that 5-flourouracil has several variations, but all have predictable reactions that need minimally a few weeks to heal, it is worth looking...

Will the withdrawl of Efalizumab effect the biologic market?

April 15, 2009

Sunil Dhawan, MD, Clinical Assistant Professor of Dermatology, STANFORD UNIVERSITY

Efalizumab withdrawn from US Market | www.medscape.com

This article is important in that the withdrawal of efalizumab by Genentech was appropriate in view of its serious side effect of progressive multifocal leukoencephalopathy (PML). This biologic agent was already declining in usage because of its other side effects, and the presence of other strongcompetitors...

Vaccinate Both Genders Against HPV

March 30, 2009

A Vaccine Debate Once Focused on Sex Shifts as Boys Join the Target Market | www.washingtonpost.com

A Vaccine Debate Once Focused on Sex Shifts as Boys Join the Target Market | www.washingtonpost.com (view article) As  the vaccine protects the men it is obvious it protects their women partners and a chain of infection is borken.  This is axiomatic in contact infection...

View All GLG News by members of this Study Group

Members in this Study Group include these company types:

  • Office Based Private Practice or Clinic
  • Academic Medical Center/Hospital or Clinic
  • Academic Institution*
  • Free-standing Surgery Center

Members in this Study Group often have these job titles:

  • Owner
  • Physician - Attending Physician
  • Physician - Director
  • President
  • Director
  • Partner
  • Physician - Division Head